Industry News
Related Searches:
Filter by:
871 - 885 of 2385 results
Prev
57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159
Next
January 12, 2011
Xcellerex, Inc. has received the Invensys Operations Management OPEN award for “innovative use of Invensys products and solutions to generate considerable business results” in four Operational Excellence categories.
Read More »
January 11, 2011
Elite Pharmaceuticals, Inc. and Hi-Tech Pharmacal Co., Inc. have entered into an agreement under which Elite will develop an intermediate for Hi-Tech for a generic version of a prescription product.
Read More »
January 11, 2011
PPD, Inc. has established a joint venture with Taijitu Biologics Ltd. (TBL), named BioDuro Biologics, to discover novel biotherapeutics.
Read More »
January 11, 2011
DSM BioSolutions, Royal DSM's microbial fermentation contract manufacturing business, and BiAqua B.V., a bio-based solutions provider for serious water contamination issues, have entered into an agreement for strain development, process development and pr
Read More »
January 10, 2011
AMT has entered into an agreement with Institut Pasteur, and a group of French research institutes (the "Consortium"), to support clinical development of a gene therapy to treat Sanfilippo B.
Read More »
January 7, 2011
Savient Pharmaceuticals provided an update on its business activities related to the U.S. launch and commercialization of Krystexxa, a PEGylated uric acid specific enzyme for the treatment of chronic gout.
Read More »
January 7, 2011
Cambrex Zenara is supplying product for Johnson & Johnson Ltd.'s launch of smoking cessation drug Nicorette in India.
Read More »
January 6, 2011
AMRI has merged its Discovery R&D and Discovery Chemistry departments to form a Global Drug Discovery organization.
Read More »
January 4, 2011
XOMA Ltd. and Les Laboratoires Servier have signed an agreement to jointly develop and commercialize XOMA 052 in multiple indications.
Read More »
January 3, 2011
Akorn, Inc.’s joint venture, Akorn-Strides LLC, has entered into a purchase agreement with Pfizer to sell 16 ANDAs and six filed ANDAs.
Read More »
January 3, 2011
BASi has entered into a Preferred Provider Agreement with NJ-based Pharmasset, Inc., a clinical-stage pharmaceutical company specializing in novel drugs to treat viral infections, to provide preclinical services for pre-IND and post-IND activities.
Read More »
December 21, 2010
Pfizer plans to recall about 19,000 bottles of Lipitor in the U.S. due to reports of an uncharacteristic odor related to the bottles, which were supplied by a third-party manufacturer.
Read More »
December 21, 2010
Eli Lilly and Co. has completed the acquisition of Avid Radiopharmaceuticals, Inc. for an upfront payment of $300 million.
Read More »
December 20, 2010
Bristol-Myers Squibb and Oncolys BioPharma, a privately-held biotechnology company based in Japan, have signed a definitive agreement under which BMS will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir.
Read More »
December 20, 2010
Gilead Sciences has signed an agreement to acquire Arresto Biosciences for $225 million and potential payments based on certain sales levels.
Read More »
871 - 885 of 2385 results
Prev
57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159
Next
